Paper · 9435295
Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction.
Xu X and 7 others. Development, 1998. Cited by 462 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Papers, record 9435295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9435295
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extremities | Major topic |
| Fibroblast Growth Factors | Major topic |
| Growth Substances | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Fibroblast Growth Factor | Major topic |
| Animals | |
| Base Sequence | |
| DNA Primers | |
| Ear, Inner | |
| Embryonic Induction | |
| Female | |
| Fibroblast Growth Factor 10 | |
| Fibroblast Growth Factor 8 | |
| Gene Expression Regulation, Developmental | |
| Male | |
| Mice | |
| Mice, Knockout | |
| Mutation | |
| Phenotype | |
| Placentation | |
| Polymerase Chain Reaction | |
| Pregnancy | |
| Receptor, Fibroblast Growth Factor, Type 2 | |
| Sequence Deletion | |
| Signal Transduction |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA60673 | NCI NIH HHS | United States | R01CA060673 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by188
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 462 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,647,227 | Frameshift Mutations in Exon 1 of Fgf10 Frequently Yield Morphologically Normal Embryos. | J Dev Biol | 2026 | https://conductscience.org/library/papers/42647227 | PubMed |
| 42,633,326 | Advances in FGF/FGFR Signaling: Implications for Disease and Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42633326 | PubMed |
| 42,429,045 | FGFR1 signaling in rheumatoid arthritis: Mechanisms of bone destruction and therapeutic targeting (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42429045 | PubMed |
| 42,281,473 | Developmental and transcriptional programs that define the initiation of the forelimb. | Development | 2026 | https://conductscience.org/library/papers/42281473 | PubMed |
| 41,981,936 | Ectopic Expression of T-Box Transcription Factors Alters Mouse Forelimb Formation. | Genesis | 2026 | https://conductscience.org/library/papers/41981936 | PubMed |
| 41,823,500 | Genetic Regulation of Wnt/PCP Components Through Fgf10/Fgfr2/Sox9 Module in Tear Duct Development. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/41823500 | PubMed |
| 41,394,637 | Developmental and transcriptional programs that define the initiation of the forelimb. | bioRxiv | 2025 | https://conductscience.org/library/papers/41394637 | PubMed |
| 40,972,968 | Genetic knockout suggests Isl1 enhancer redundancy in mouse hindlimb development. | Dev Biol | 2025 | https://conductscience.org/library/papers/40972968 | PubMed |
| 40,454,573 | Feto-placental blood vessel development. | Development | 2025 | https://conductscience.org/library/papers/40454573 | PubMed |
| 40,257,501 | Increased thermal stability of FGF10 leads to ectopic signaling during development. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40257501 | PubMed |
1 to 10 of 188
See all 188 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9435295
GET https://conductscience.org/api/papers/v1/9435295/cited_by?page=2